These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 37880775)

  • 21. Idiopathic normal-pressure hydrocephalus, cerebrospinal fluid biomarkers, and the cerebrospinal fluid tap test.
    Kang K; Ko PW; Jin M; Suk K; Lee HW
    J Clin Neurosci; 2014 Aug; 21(8):1398-403. PubMed ID: 24836892
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuronal pentraxin 2 correlates with neurodegeneration but not cognition in idiopathic normal pressure hydrocephalus (iNPH).
    Patel M; Zhang Y; Xiao MF; Worley P; Moghekar A
    Neurol Neurochir Pol; 2024; 58(1):47-53. PubMed ID: 38393959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebrospinal fluid biomarkers for prognosis of long-term cognitive treatment outcomes in patients with idiopathic normal pressure hydrocephalus.
    Nakajima M; Miyajima M; Ogino I; Akiba C; Sugano H; Hara T; Fusegi K; Karagiozov K; Arai H
    J Neurol Sci; 2015 Oct; 357(1-2):88-95. PubMed ID: 26169158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo assessment of Lewy body and beta-amyloid copathologies in idiopathic normal pressure hydrocephalus: prevalence and associations with clinical features and surgery outcome.
    Giannini G; Baiardi S; Dellavalle S; Zenesini C; Cevoli S; Danner N; Jyrkkänen HK; Rossi M; Polischi B; Quadalti C; Stefanini C; Cortelli P; Milletti D; Herukka SK; Palandri G; Leinonen V; Parchi P
    Fluids Barriers CNS; 2022 Sep; 19(1):71. PubMed ID: 36071460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subtle Differences in Cognition in 70-Year-Olds with Elevated Cerebrospinal Fluid Neurofilament Light and Neurogranin: A H70 Cross-Sectional Study.
    Rådestig MA; Skoog J; Zetterberg H; Skillbäck T; Zettergren A; Sterner TR; Fässberg MM; Sacuiu S; Waern M; Wetterberg H; Blennow K; Skoog I; Kern S
    J Alzheimers Dis; 2023; 91(1):291-303. PubMed ID: 36617786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Idiopathic normal pressure hydrocephalus has a different cerebrospinal fluid biomarker profile from Alzheimer's disease.
    Jingami N; Asada-Utsugi M; Uemura K; Noto R; Takahashi M; Ozaki A; Kihara T; Kageyama T; Takahashi R; Shimohama S; Kinoshita A
    J Alzheimers Dis; 2015; 45(1):109-15. PubMed ID: 25428256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cerebrospinal fluid Aβ42, t-tau, and p-tau levels in the differential diagnosis of idiopathic normal-pressure hydrocephalus: a systematic review and meta-analysis.
    Chen Z; Liu C; Zhang J; Relkin N; Xing Y; Li Y
    Fluids Barriers CNS; 2017 May; 14(1):13. PubMed ID: 28486988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer's continuum.
    Milà-Alomà M; Salvadó G; Gispert JD; Vilor-Tejedor N; Grau-Rivera O; Sala-Vila A; Sánchez-Benavides G; Arenaza-Urquijo EM; Crous-Bou M; González-de-Echávarri JM; Minguillon C; Fauria K; Simon M; Kollmorgen G; Zetterberg H; Blennow K; Suárez-Calvet M; Molinuevo JL;
    Alzheimers Dement; 2020 Oct; 16(10):1358-1371. PubMed ID: 32573951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ventricular volume in relation to lumbar CSF levels of amyloid-β 1-42, tau and phosphorylated tau in iNPH, is there a dilution effect?
    Lidén S; Farahmand D; Laurell K
    Fluids Barriers CNS; 2022 Jul; 19(1):59. PubMed ID: 35843939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential proteomic profile of lumbar and ventricular cerebrospinal fluid.
    Rostgaard N; Olsen MH; Ottenheijm M; Drici L; Simonsen AH; Plomgaard P; Gredal H; Poulsen HH; Zetterberg H; Blennow K; Hasselbalch SG; MacAulay N; Juhler M
    Fluids Barriers CNS; 2023 Jan; 20(1):6. PubMed ID: 36670437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two-Point Dynamic Observation of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Idiopathic Normal Pressure Hydrocephalus.
    Jingami N; Uemura K; Asada-Utsugi M; Kuzuya A; Yamada S; Ishikawa M; Kawahara T; Iwasaki T; Atsuchi M; Takahashi R; Kinoshita A
    J Alzheimers Dis; 2019; 72(1):271-277. PubMed ID: 31561378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clarifying the association of CSF Aβ, tau, BACE1, and neurogranin with AT(N) stages in Alzheimer disease.
    Lehmann S; Schraen-Maschke S; Buée L; Vidal JS; Delaby C; Hirtz C; Blanc F; Paquet C; Allinquant B; Bombois S; Gabelle A; Hanon O;
    Mol Neurodegener; 2024 Oct; 19(1):66. PubMed ID: 39380095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebrospinal Fluid Biomarkers in Cerebral Amyloid Angiopathy.
    Banerjee G; Ambler G; Keshavan A; Paterson RW; Foiani MS; Toombs J; Heslegrave A; Dickson JC; Fraioli F; Groves AM; Lunn MP; Fox NC; Zetterberg H; Schott JM; Werring DJ
    J Alzheimers Dis; 2020; 74(4):1189-1201. PubMed ID: 32176643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preoperative Phosphorylated Tau Concentration in the Cerebrospinal Fluid Can Predict Cognitive Function Three Years after Shunt Surgery in Patients with Idiopathic Normal Pressure Hydrocephalus.
    Nakajima M; Miyajima M; Ogino I; Akiba C; Kawamura K; Kamohara C; Fusegi K; Harada Y; Hara T; Sugano H; Tange Y; Karagiozov K; Kasuga K; Ikeuchi T; Tokuda T; Arai H
    J Alzheimers Dis; 2018; 66(1):319-331. PubMed ID: 30248058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The predictive value of T-tau and AB1-42 levels in idiopathic normal pressure hydrocephalus.
    Craven CL; Baudracco I; Zetterberg H; Lunn MPT; Chapman MD; Lakdawala N; Watkins LD; Toma AK
    Acta Neurochir (Wien); 2017 Dec; 159(12):2293-2300. PubMed ID: 28889317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Comparison of Cerebrospinal Fluid Beta-Amyloid and Tau in Idiopathic Normal Pressure Hydrocephalus and Neurodegenerative Dementias.
    Said HM; Kaya D; Yavuz I; Dost FS; Altun ZS; Isik AT
    Clin Interv Aging; 2022; 17():467-477. PubMed ID: 35431542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of coexistence of Alzheimer's disease in idiopathic normal pressure hydrocephalus using ELISA analyses for CSF biomarkers.
    Lim TS; Choi JY; Park SA; Youn YC; Lee HY; Kim BG; Joo IS; Huh K; Moon SY
    BMC Neurol; 2014 Apr; 14():66. PubMed ID: 24690253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PTI-125 Reduces Biomarkers of Alzheimer's Disease in Patients.
    Wang HY; Pei Z; Lee KC; Lopez-Brignoni E; Nikolov B; Crowley CA; Marsman MR; Barbier R; Friedmann N; Burns LH
    J Prev Alzheimers Dis; 2020; 7(4):256-264. PubMed ID: 32920628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between high biomarker probability of Alzheimer's disease and improvement of clinical outcomes after shunt surgery in patients with idiopathic normal pressure hydrocephalus.
    Kazui H; Kanemoto H; Yoshiyama K; Kishima H; Suzuki Y; Sato S; Suehiro T; Azuma S; Yoshimine T; Tanaka T
    J Neurol Sci; 2016 Oct; 369():236-241. PubMed ID: 27653897
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebrospinal Fluid Biomarkers in Idiopathic Normal Pressure Hydrocephalus versus Alzheimer's Disease and Subcortical Ischemic Vascular Disease: A Systematic Review.
    Manniche C; Hejl AM; Hasselbalch SG; Simonsen AH
    J Alzheimers Dis; 2019; 68(1):267-279. PubMed ID: 30741681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.